Association of interleukin-15 single nucleotide polymorphisms with resistance to brucellosis among Iranian patients

Tissue Antigens

Volumn 78, Issue 5, 2011, Pages 352-358

  Kalani, M ^a   Rasouli, M ^a   Moravej, A ^a   Kiany, S ^a   Rahimi, H R ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Brucellosis; Genetic polymorphisms; Interleukin 15; Iran

Indexed keywords

INTERLEUKIN 15;

ADOLESCENT; ADULT; AGED; ARTICLE; BRUCELLOSIS; CHILD; CONTROLLED STUDY; FEMALE; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; INFECTION RESISTANCE; INFECTION SENSITIVITY; IRAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALLELES; BRUCELLOSIS; CHILD; DISEASE RESISTANCE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN-15; IRAN; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

ANIMALIA;

EID: 80053930615     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2011.01775.x     Document Type: Article

References (46)

1. Corbel MJ. Brucellosis: an overview. Emerg Infect Dis 1997: 3: 213-21.
2. Corbel MJ. Brucellosis in Human and Animals. Geneva: World Health Organization, 2006, 1.
3. Refai M. Incidence and control of brucellosis in the Near East region. Vet Microbiol 2002: 90: 81-110.
4. Pappas G, Akritidis N, Bosilkovski M, Tsianos E. Brucellosis. N Engl J Med 2005: 352: 2325-36.
5. Sharda DC, Lubani M. A study of brucellosis in childhood. Clin Pediatr (Phila) 1986: 25: 492-5.
6. Golding B, Scott DE, Scharf O et al. Immunity and protection against Brucella abortus. Microbes Infect 2001: 3: 43-8.
7. Pasqual P, Adone R, Gasbarre LC, Pistoia C, Ciuchini F. Mouse cytokine profiles associated with Brucella abortus RB51 vaccination or Brucella abortus 2308 infection. Infect Immun 2001: 69: 6541-4.
8. Jiang X, Baldwin CL. Effects of cytokines on intracellular growth of Brucella abortus. Infect Immun 1993: 61: 124-34.
9. Zhan Y, Liu Z, Cheers C. Tumor necrosis factor alpha and interleukin-12 contribute to resistance to the intracellular bacterium Brucella abortus by different mechanisms. Infect Immun 1996: 64: 2782-8.
10. Fernandes DM, Jiang X, Jung JH, Baldwin CL. Comparison of T cell cytokines in resistant and susceptible mice infected with virulent Brucella abortus strain 2308. FEMS Immunol Med Microbiol 1996: 16: 193-203.
11. Zaitseva MB, Golding H, Betts M et al. Human peripheral blood CD4+ and CD8+ T cells express Th1-like cytokine mRNA and proteins following in vitro stimulation with heat-inactivated Brucella abortus. Infect Immun 1995: 63: 2720-8.
12. Zhan Y, Cheers C. Control of IL-12 and IFN-gamma production in response to live or dead bacteria by TNF and other factors. J Immunol 1998: 161: 1447-53.
13. Carson WE, Giri JG, Lindemann MJ et al. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J Exp Med 1994: 180: 1395-403.
14. Armitage RJ, Macduff BM, Eisenman J, Paxton R, Grabstein KH. IL-15 has stimulatory activity for the induction of B cell proliferation and differentiation. J Immunol 1995: 154: 483-90.
15. Kennedy MK, Park LS. Characterization of interleukin-15 (IL-15) and the IL-15 receptor complex. J Clin Immunol 1996: 16: 134-43
16. Yoshikai Y, Nishimura H. The role of interleukin-15 in mounting an immune response against microbial infection. Microbes Infect 2000: 2: 381-9.
17. Kutzler MA, Robinson TM, Chattergoon MA et al. Coimmunization with an optimized IL-15 plasmid results in enhanced function and longevity of CD8 T cells that are partially independent of CD4 T cell help. J Immunol 2005: 175: 112-23.
18. Bannwart CF, Nakaira ET, Sartori A, Peracoli MTS. Interleukin-15: its role in microbial infections. J Venom Anim Toxins Incl Trop Dis 2007: 13: 562-75.
19. Hu XD, Chen ST, Li JY, Yu DH, Yi-Zhang H, Cai H. An IL-15 adjuvant enhances the efficacy of a combined DNA vaccine against Brucella by increasing the CD8+ cytotoxic T cell response. Vaccine 2010: 28: 2408-15.
20. Hajilooi M, Rafiei A, Reza Zadeh M, Tajik N. Association of interleukin-1 receptor antagonist gene polymorphism and susceptibility to human brucellosis. Tissue Antigens 2006: 68: 331-4.
21. Kamali-Sarvestani E, Rasouli M, Mortazavi H, Gharesi-Fard B. Cytokine gene polymorphisms and susceptibility to cutaneous leishmaniasis in Iranian patients. Cytokine 2006: 35: 159-65.
22. Bravo MJ, Colmenero JD, Martín J, Alonso A, Caballero A. Polymorphism of the transmembrane region of the MICA gene and human brucellosis. Tissue Antigens 2007: 69: 358-60.
23. Rasouli M, Kiany S, Behbin M. Interleukin-10 gene polymorphisms and susceptibility to brucellosis in Iranian patients. Iran J Immunol 2008: 5: 131-5.
24. Lin D, Liu C, Xue M et al. The role of interleukin-15 polymorphisms in adult acute lymphoblastic leukemia. PLoS One 2010: 5: e13626.
25. Zhang XJ, Yan KL, Wang ZM et al. Polymorphisms in interleukin-15 gene on chromosome 4q31.2 are associated with psoriasis vulgaris in Chinese population. J Invest Dermatol 2007: 127: 2544-51.
26. Rasouli M, Kalani M, Moravej A, Kiany S. Interleukin-18 single nucleotide polymorphisms contribute to the susceptibility to Brucellosis in Iranian patients. Cytokine 2011: 54: 272-76.
27. Karaoglan I, Pehlivan S, Namiduru M et al. TNF-α, TGF-β, IL-10, IL-6 and IFN-γ gene polymorphisms as risk factors for brucellosis. New Microbiol 2009: 32: 173-8.
28. Rasouli M, Kiany S, Moravej A, Kalani M. Interleukin-12 and tumor necrosis factor-β gene polymorphisms as genetic susceptibility factors for Brucellosis in Iranian patients. Iran Red Crescent Med J 2010: 12: 266-71.
29. Rasouli M, Kiany S. Association of interferon gamma and interleukin-4 gene polymorphisms with susceptibility to brucellosis in Iranian patients. Cytokine 2007: 38: 49-53.
30. Manohar K, Suneetha PV, Sukriti et al. Association of IL-18 promoter polymorphism with liver disease severity in HCV-infected patients. Hepatol Int 2009: 3: 371-7.
31. Yajima T, Yoshihara K, Nakazato K et al. IL-15 regulates CD8+ T cell contraction during primary infection. J Immunol 2006: 176: 507-15.
32. Rueda B, Lopez-Nevot MA, Gonzalez-Gay MA et al. Molecular screening and association study of IL15 gene polymorphisms in rheumatoid arthritis. Cytokine 2007: 38: 84-9.
33. Cahide G, Makbule A, Elif O et al. Influences of genetic variants in interleukin-15 gene and serum interleukin-15 levels on coronary heart disease. Cytokine 2010: 49: 58-63.
34. Fehniger TA, Caligiuri MA. Interleukin 15: biology and relevance to human disease. Blood 2001: 97: 14-32.
35. Pravica V, Perrey C, Stevens A, Lee JH, Hutchinson IV. A single nucleotide polymorphism in the first intron of the human IFN-gamma gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-gamma production. Hum Immunol 2000: 61: 863-6.
36. Giedraitis V, He B, Huang WX, Hillert J. Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation. J Neuroimmunol 2001: 112: 146-52.
37. Liang XH, Cheung W, Heng CK, Wang DY. Reduced transcriptional activity in individuals with IL-18 gene variants detected from functional but not association study. Biochem Biophys Res Commun 2005: 338: 736-41.
38. Schork NJ, Cardon LR, Xu X. The future of genetic epidemiology. Trends Genet 1998: 14: 266-72.
39. Tishkoff SA, Pakstis AJ, Ruano G, Kidd KK. The accuracy of statistical methods for estimation of haplotype frequencies: an example from the CD4 locus. Am J Hum Genet 2000: 67: 518-22.
40. Clark VJ, Metheny N, Dean M, Peterson RJ. Statistical estimation and pedigree analysis of CCR2-CCR5 haplotypes. Hum Genet 2001: 108: 484-93.
41. Conne B, Stutz A, Vassalli JD. The 3' untranslated region of messenger RNA: a molecular "hotspot" for pathology. Nat Med 2000: 6: 637-41.
42. Pistilli EE, Devaney JM, Gordish-Dressman H et al. Interleukin-15 and interleukin-15Rα SNPs and associations with muscle, bone, and predictors of the metabolic syndrome. Cytokine 2008: 43: 45-53.
43. Andrews C. The Hardy-Weinberg principle. Nat Educ Knowl 2010: 1: 65.
44. Budak F, Göral G, Heper Y et al. IL-10 and IL-6 gene polymorphisms as potential host susceptibility factors in Brucellosis. Cytokine 2007: 38: 32-6.
45. Sambatakou H, Pravica V, Hutchinson IV, Denning DW. Cytokine profiling of pulmonary aspergillosis. Int J Immunogenet 2006: 33: 297-302.
46. Kurz T, Strauch K, Dietrich H et al. Multilocus haplotype analyses reveal association between 5 novel IL-15 polymorphisms and asthma. J Allergy Clin Immunol 2004: 113: 896-901.